CLVR vs MRK · rev $17.4M vs P/E 33, rev $16.61B
Clever Leaves Holdings Inc (CLVR) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Clever Leaves Holdings Inc (CLVR) is a drug manufacturers - specialty & generic company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported CLVR revenue for 2023-12-31 was $17.4M. Net income was -$17.9M. Revenue was up 6.1% from 2022-12-31 to 2023-12-31. CLVR currently screens at market cap $1.4K.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
CLVR currently screens at market cap $1.4K. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the CLVR and MRK stock pages for the full models.
Not investment advice.